“…(fi)-(-)-2-[[iV-[l-(lH-Imidazol-4-yl)-2-propyl]imino]phenylmethyl]phenol (9a): method A (yield 35%) or method B (yield 85%); crystallized from EtOAc/CeHX2; -NMR (DMSOde) <3 15.63 (s* 1H, NH), 11.73 (br*, 1H, OH), 7.53 (m, 4H, Ph-2-H, Ph-4-H, Ph-6-H, imidazole-2-H), 7.26 (m, 3H, Ph-3-H, Ph-5-H, HOPh-5-íf), 6.74 (m, 4H, HOPh-3-tf, HOPh-4-H, HOPh-6-H, imidazole-5-H), 3.53 (m, 1H, CH), 2.73 (d, 2H, J = 6, CH2), 1.15 (d, 3H, J = 6, CH3). Anal. (fZ)-(-)-2-[[lV-[l-(lff-Imidazol-4-yl)-2-propyl]immo](2-hydroxyphenyI)methyl]phenol (9b): method A; crystallized from EtOAc/C6Hi2; -NMR (DMSO-d6) 15.77 (br*, 0.64H, NH), 15.65 (br*, 0.36H, NH), 11.75 (br*, 1H, (E)-OH), 9.90 (br*, IH, (Z)-OH), 7.49-6.41 (m, 10 H, 8Ph-H, imidazole-2-H, imidazole-5-H), 3.55 (m, 1H, CH), 2.87-2.69 (m, 2H, CH2), 1.17 (d, 0.64 3H, J = 6.2, CH3), 1.06 (d, 0.36 3H, J = 6.2, CH3). (br*, 1H, Ph-2-OH), 9.92 (s*, 1H, Ph-4-OH), 7.48 (m, 4H, Ph-2-H, Ph-4-H, Ph-6-H, imidazole-2-H), 7.23-6.64 (m, 3H, Ph-3, Ph-5-H, imidazole-5-H), 6.33 (d, 1H, J = 8.7, HOPh-3-), 6.17 .49 (m, 6H, 5Ph-H, imidazole-2-H), 6.63 (s, 1H, imidazole-5-H), 6.41 (d, 1H, J = 8.9, HOPh-3-tf), 6.33 (s, 1H, HOPh-6-JT), 6.41 (d, 1H, J = 8.9, HOPh-4-ií), 3.50 (br*, 1H, OH), 7.52 (m, 4H, Ph-2-H, Ph-4-H, Ph-6-H, imidazole-2-H), 7.17 (m, 1H, HOPh-5-tf), 6.92 (m, 3H, Ph-3-H, Ph-5-H, HOPh-6-fl), 6.64 (s, 1H, imidazole-5-H), 6.23 (m, 1H, HOPh-3-H), 3.53 imino]phenylmethyl]phenol (9g): method B; crystallized from EtOAc/C6HX2; -NMR (DMSO-de) ó 15.81 (s*, 1H, NH), 11.75 (br*, 1H, OH), 7.52 (m, 4H, Ph-2-H, Ph-4-H, Ph-6-H, imidazole-2-H), 7.32 (dd, 1H, 3J = 8.8, 4J = 2.7, HOPh-5-H), 6.94 (m, 3H, Ph-3-H, Ph-5-H, HOPh-6-tf), 6.64 (s, 1H, imidazole-5-H), 6.47 (d, 1H, 4J = 2.7, HOPh-3-H), 3.54 (m, 1H, CH), 2.73 (d, 2H, J = 6.3, CH2), 1.16 (d, 3H, J = 6.4, CH3).…”